retatrutide data New Phase 3 dropped and everyone's running with the big number. 30% body weight loss at 12mg. Impressive headline. But nobody's talking about 4mg. 📊 19% body weight loss 📊 Lilly orforglipron oral GLP-1 phase

Botanical Blend for Everyday Use: Each capsule includes ingredients such as berberine, capsimax, chromium, and apple cider vinegar powderpopular in modern wellness routines

"Important update: Medically accepted indication edit." Provider notice, June 2023

As long as a drug is under patent, the original manufacturer has exclusive rights to sell it, keeping prices high

Moreover, exogenous administration of GLP-1R agonists failed to reduce food intake (and gastric emptying) in Glp1r Wnt1- / - mice or Glp1r conditional KO mice, reflecting the importance of neural GLP-1R populations for the pharmacological control of GLP-1-regulated feeding [194,198]

multiple stress-related stimuli cause its activation and opening with subsequent membrane depolarization

FDA Safety Announcement: Soliqua FDA Safety Label Change and Revised Drug Label Trulicity (active ingredient: dulaglutide) subcutaneous injection Initial FDA Approval: 2014 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting